Contact this trialFirst, we need to learn more about you.
PD-1 Inhibitor
SC Pembrolizumab + Hyaluronidase for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Clermont, Florida
This trial will compare SC MK-3475A to IV pembrolizumab as first-line treatment for metastatic non-small cell lung cancer, assessing safety & how drugs are processed by the body.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.